Assessment of Oral Poliovirus Vaccine Viability and Titer at Delivery Points in Kinshasa, the Democratic Republic of the Congo: Implications for Cold Chain Management. [PDF]
Kashitu-Mujinga G +14 more
europepmc +1 more source
Increasing Population Immunity Prior to Globally-Coordinated Cessation of Bivalent Oral Poliovirus Vaccine (bOPV). [PDF]
Badizadegan ND +6 more
europepmc +1 more source
Post-vaccination campaign evaluation of systemic and mucosal immunity of trivalent oral poliovirus vaccine in Karachi, Pakistan (2020-2021): a cross-sectional study. [PDF]
Saleem AF +9 more
europepmc +1 more source
Expected RATE of Vaccine-Associated Paralytic Poliomyelitis: A Simulation Analysis Regarding Transition from the Trivalent to Bivalent Oral Poliovirus Vaccine. [PDF]
Yasri S, Wiwanitkit V.
europepmc +1 more source
Immunogenicity evaluation of primary polio vaccination schedule with inactivated poliovirus vaccines and bivalent oral poliovirus vaccine. [PDF]
Xu J +10 more
europepmc +1 more source
Expected Implications of Globally Coordinated Cessation of Serotype 3 Oral Poliovirus Vaccine (OPV) Before Serotype 1 OPV. [PDF]
Kalkowska DA, Thompson KM.
europepmc +1 more source
Application of MPBT Assay for Multiplex Determination of Infectious Titers and for Selection of the Optimal Formulation for the Trivalent Novel Oral Poliovirus Vaccine. [PDF]
Manukyan H +8 more
europepmc +1 more source
Sequential inactivated and oral poliovirus vaccine schedules: a balancing act. [PDF]
Zaman K, Anand A.
europepmc +1 more source
Updated Characterization of Outbreak Response Strategies for 2019-2029: Impacts of Using a Novel Type 2 Oral Poliovirus Vaccine Strain. [PDF]
Kalkowska DA +9 more
europepmc +1 more source
The Immunogenicity of Monovalent Oral Poliovirus Vaccine Type 1 (mOPV1) and Inactivated Poliovirus Vaccine (IPV) in the EPI Schedule of India. [PDF]
Mohanty L +5 more
europepmc +1 more source

